Do you know the latest trends in Pharmacovigilance in Asia?



Worth of Asia’s Pharmaceutical Market



Of 18 – 24-year-olds trust medical information shared on social media


More than 100

Approved drugs with labels that contain information on genomic biomarkers



Highest fine to date for off-label promotion


This lucrative market in Asia remains extremely complicated and fast changing. Make sure you arm yourself with the latest information to stay ahead of your competitors…

Elevating PV Quality and Compliance via Community Collaboration and Digital Health Applications

The 7th Annual Pharmacovigilance Asia Summit once again gathers global and regional regulators together with industry experts to tackle the latest challenges in proactively building and managing a risk-management programme. What are the new quantitative methods in benefit-risk evaluation? How do you create a PV-focused culture and what is the role of the QPPV in Asia? How has digital health initiatives had an impact on the cost and accuracy of PV? How do you leverage on mobile applications to enhance medication adherence and patient support compliance?

We’ll be answering these questions and more as we bring together experts from Europe and APAC!

Download Agenda

Learn from academic and health authority speakers

View All Speakers

Key Topics in 2016 Include:


The latest PV legislation

how will developments in US and Europe affect Asia?

Leveraging digital health applications

to enhance patient support through detecting and managing safety signals and enhance patient support

Pro-actively negotiating risk management plans

and benefit-risk evaluation in Asia – both quantitative and qualitative approaches

Creating a PV-focused culture

and ensuring quality assurance across people, process and technologies

Ensuring continuity and compliance

in M&A environment

How to effectively communicate risk

through education, awareness, and collaboration with the community

Top Reasons to Attend


Covering the breadth of international and regional regulatory bodies – European Medical Agency (EMA), and non ICH countries across Asia Pacific


ONLY Asia event unveiling the latest updates from ISoP’s Special Interest Group on Risk Minimisation Methods in Asia


Exclusive: special hands-on mobile application evaluation session where you get to try your hand at the latest digital PV technologies


Derive a holistic understanding from both very technical (beginner) levels and more advanced and strategic points of view


In-depth case studies from leading companies in the region and interactive multi-stakeholder debates


Download Agenda

Media Partners